- Home
- SRG vs SXTC Comparison
SRG vs SXTC Comparison
Compare SRG & SXTC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SRG
- SXTC
- Stock Information
- Founded
- SRG 2014
- SXTC 2005
- Country
- SRG United States
- SXTC China
- Employees
- SRG N/A
- SXTC 75
- Industry
- SRG Real Estate Investment Trusts
- SXTC Biotechnology: Pharmaceutical Preparations
- Sector
- SRG Real Estate
- SXTC Health Care
- Exchange
- SRG Nasdaq
- SXTC Nasdaq
- Market Cap
- SRG 185.9M
- SXTC 186.8M
- IPO Year
- SRG 2015
- SXTC 2019
- Fundamental
- Price
- SRG $2.85
- SXTC $1.60
- Analyst Decision
- SRG
- SXTC
- Analyst Count
- SRG 0
- SXTC 0
- Target Price
- SRG N/A
- SXTC N/A
- AVG Volume (30 Days)
- SRG 104.5K
- SXTC 72.8K
- Earning Date
- SRG 08-22-2025
- SXTC 01-01-0001
- Dividend Yield
- SRG N/A
- SXTC N/A
- EPS Growth
- SRG N/A
- SXTC N/A
- EPS
- SRG N/A
- SXTC N/A
- Revenue
- SRG N/A
- SXTC $1,740,907.00
- Revenue This Year
- SRG N/A
- SXTC N/A
- Revenue Next Year
- SRG N/A
- SXTC N/A
- P/E Ratio
- SRG N/A
- SXTC N/A
- Revenue Growth
- SRG N/A
- SXTC N/A
- 52 Week Low
- SRG $2.43
- SXTC $0.95
- 52 Week High
- SRG $4.85
- SXTC $8.64
- Technical
- Relative Strength Index (RSI)
- SRG 35.98
- SXTC 48.05
- Support Level
- SRG $2.81
- SXTC $1.50
- Resistance Level
- SRG $2.95
- SXTC $1.66
- Average True Range (ATR)
- SRG 0.12
- SXTC 0.10
- MACD
- SRG -0.04
- SXTC 0.01
- Stochastic Oscillator
- SRG 6.90
- SXTC 45.83
About SRG Seritage Growth Properties
Seritage Growth Properties is principally engaged in the ownership, development, redevelopment, management, and leasing of diversified and mixed-use properties throughout the United States.
About SXTC China SXT Pharmaceuticals Inc.
China SXT Pharmaceuticals Inc is a pharmaceutical company that is focused on the research, development, manufacture, marketing, and sales of Traditional Chinese Medicine Pieces (TCMP), particularly, TCMP (Directed-oral TCMP, and After-soaking TCMP) which is a sort of Traditional Chinese Medicine (TCM) that has been processed to be ready for use without decoction. Geographically, the firm generates its revenue from the People's Republic of China.